Evaluation of Cell‐Extracellular Vesicle Interaction Using a Microfluidic Microsystem ( Cell ExoChip)
Source abstract
Abstract
Abstract Metastasis remains a misunderstood concept that contributes to ≈90% of cancer‐related deaths. Despite theories regarding the “Seed‐and‐Soil” hypothesis, many mechanisms of metastasis remain unclear. Recent research highlights exosomes as potential factors for preparing the microenvironment (soil) for organotropic metastasis. Cell‐secreted exosomes play key roles in intercellular‐communication by exchanging information in the form of proteins and nucleic acids. Additionally, tumor‐derived exosomes (TDEs) demonstrate organotropic tendencies, facilitating metastasis through cellular transfer of cancerous materials. However, the cellular uptake of exosomes and cell response to exosome interactions has yet to be thoroughly studied in respect to organotropism. To address this gap, the Cell ExoChip is developed, a microfluidic device that studies the organ‐preferred exosome‐cell interactions using cancer‐derived cells and exosomes. Utilizing the Cell ExoChip, lung cancer cells tend are offered to have the highest exosome uptake compared to bladder and breast cell lines, enhancing their ability to transfer material and influence physiological conditions. Then, the impact of certain organ‐derived exosomes are analyzed on the cell exosome secretion rate from cells of different organ‐types, revealing lung exosomes having an increase in metastatic tendencies through enhancing exosome secretion post‐uptake of exosomes from various organs. These novel findings fill a critical gap in understanding the role of exosomes in metastasis and the potential of using the Cell ExoChip for studying and predicating metastasis.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Blood properties and coagulation · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical Engineering and Biointerface Institute University of Michigan 2800 Plymouth Road, NCRC B10‐A184 Ann Arbor MI 48109 USA
Department of Mechanical Engineering University of Michigan Ann Arbor MI 48109 USA
Biointerfaces Institute University of Michigan 2800 Plymouth Rd Ann Arbor MI 48105 USA
Rogel Cancer Center University of Michigan 1500 E Medical Center Dr Ann Arbor MI 48109 USA
References (51)
Show source-provided references
1. 10.1259/bjr.2019052410.1259/bjr.20190524 ↗
2. Han Y. · JNCI Cancer Spectr · 2021 · 5
3. 10.1016/j.eururo.2023.08.01610.1016/j.eururo.2023.08.016 ↗
4. 10.1615/CritRevOncog.v18.i1-2.4010.1615/CritRevOncog.v18.i1-2.40 ↗
5. Jandial R. · 2013
6. 10.1016/j.semcancer.2023.05.00310.1016/j.semcancer.2023.05.003 ↗
7. 10.1186/s40164-021-00223-410.1186/s40164-021-00223-4 ↗
8. 10.4081/oncol.2017.32110.4081/oncol.2017.321 ↗
9. 10.1002/jbmr.361810.1002/jbmr.3618 ↗
10. 10.1016/j.biomaterials.2017.10.03310.1016/j.biomaterials.2017.10.033 ↗
11. 10.1158/0008-5472.CAN-12-220210.1158/0008-5472.CAN-12-2202 ↗
12. 10.1016/j.cell.2008.01.04610.1016/j.cell.2008.01.046 ↗
13. 10.1016/j.canlet.2005.06.02110.1016/j.canlet.2005.06.021 ↗
14. 10.1038/s41698-018-0047-010.1038/s41698-018-0047-0 ↗
15. 10.1007/s10911-007-9047-310.1007/s10911-007-9047-3 ↗
16. 10.1038/s41392-020-0134-x10.1038/s41392-020-0134-x ↗
17. 10.1016/j.yexcr.2021.11252710.1016/j.yexcr.2021.112527 ↗
18. 10.1038/nri85510.1038/nri855 ↗
19. 10.1098/rstb.2013.050210.1098/rstb.2013.0502 ↗
20. 10.1002/jev2.1214410.1002/jev2.12144 ↗
21. 10.3390/ijms2112446310.3390/ijms21124463 ↗
22. 10.1016/S1535-6108(02)00153-810.1016/S1535-6108(02)00153-8 ↗
23. 10.1016/j.lfs.2021.12021610.1016/j.lfs.2021.120216 ↗
24. 10.1080/20013078.2019.159968010.1080/20013078.2019.1599680 ↗
25. 10.1186/s12929-024-00994-y10.1186/s12929-024-00994-y ↗
26. 10.1016/j.bbagen.2024.13075210.1016/j.bbagen.2024.130752 ↗
27. 10.1016/j.neo.2020.11.01110.1016/j.neo.2020.11.011 ↗
28. 10.1038/s41467-017-02583-010.1038/s41467-017-02583-0 ↗
29. 10.1158/0008-5472.CAN-10-172210.1158/0008-5472.CAN-10-1722 ↗
30. 10.1038/nm.275310.1038/nm.2753 ↗
31. 10.1002/advs.20200374710.1002/advs.202003747 ↗
32. 10.1039/C9AN01235D10.1039/C9AN01235D ↗
33. 10.1016/j.jconrel.2016.11.01610.1016/j.jconrel.2016.11.016 ↗
34. 10.1002/cam4.693610.1002/cam4.6936 ↗
35. 10.1039/C4LC00136B10.1039/C4LC00136B ↗
36. F. C. Shop How to Choose Your Lab‐on‐a‐Chip. 2023 Webpage FireFlyScience.com https://www.fireflysci.com/news/2023/5/10/how‐to‐choose‐your‐lab‐on‐a‐chip?srsltid=AfmBOopxzB5sxPoBILbDxoxYIHUSnRtG‐Zrfhk4am‐RnrlK5FzxnLIHo.
37. 10.1038/nature1575610.1038/nature15756 ↗
38. 10.1186/s12943-019-0963-910.1186/s12943-019-0963-9 ↗
39. 10.3390/ijms2307353410.3390/ijms23073534 ↗
40. 10.1021/acsnano.0c0477810.1021/acsnano.0c04778 ↗
41. 10.1063/5.022084010.1063/5.0220840 ↗
42. Wang L. · Cancer Biol. Med. · 2014 · 11 · 208
43. 10.5489/cuaj.30710.5489/cuaj.307 ↗
44. J. H. M Group. Bladder Cancer Treatment 2024 Wedpage HopkinsMedicine.org https://www.hopkinsmedicine.org/health/conditions‐and‐diseases/bladder‐cancer/bladder‐cancer‐treatment#:~:text=Muscle%2Dinvasive%20bladder%20cancer%2C%20or%20advanced%20bladder%20cancer%2C These%20cancers%20require%20more%20aggressive%20clinical%20management.
45. Lung cancer ‐ small cell Mount Sinai 2023. Mountsinai.org https://www.mountsinai.org/health‐library/diseases‐conditions/lung‐cancer‐small‐cell.
46. 10.3390/jcm1204137510.3390/jcm12041375 ↗
47. 10.3322/caac.2165410.3322/caac.21654 ↗
48. Ahmad A. · 2017
49. 10.1111/joim.1208410.1111/joim.12084 ↗
50. 10.1186/s13578-022-00887-310.1186/s13578-022-00887-3 ↗
51. 10.1002/celc.20240018210.1002/celc.202400182 ↗